THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA
dc.authorid | kucuksahin, orhan/0000-0003-4530-2304 | |
dc.authorid | turk, sumeyye merve/0000-0003-0662-4837 | |
dc.authorid | Gonullu, Emel/0000-0002-6990-4206 | |
dc.authorid | Yilmaz, Recep/0000-0001-8806-8621 | |
dc.contributor.author | Gonullu, E. | |
dc.contributor.author | Kalyoncu, U. | |
dc.contributor.author | Yagiz, B. | |
dc.contributor.author | Ates, A. | |
dc.contributor.author | Kucuksahin, O. | |
dc.contributor.author | Bilge, S. Yasar | |
dc.contributor.author | Kanitez, N. A. | |
dc.date.accessioned | 2024-09-18T21:01:51Z | |
dc.date.available | 2024-09-18T21:01:51Z | |
dc.date.issued | 2022 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description | EULAR European Congress of Rheumatology (EULAR) -- JUN 01-04, 2022 -- Copenhagen, DENMARK | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Alliance Assoc Rheumatol | en_US |
dc.identifier.doi | 10.1136/annrheumdis-2022-eular.2721 | |
dc.identifier.endpage | 1304 | en_US |
dc.identifier.issn | 0003-4967 | |
dc.identifier.issn | 1468-2060 | |
dc.identifier.startpage | 1304 | en_US |
dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2022-eular.2721 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/13044 | |
dc.identifier.volume | 81 | en_US |
dc.identifier.wos | WOS:000850279005213 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bmj Publishing Group | en_US |
dc.relation.ispartof | Annals of The Rheumatic Diseases | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA | en_US |
dc.type | Conference Object | en_US |